Immune Checkpoint Inhibitors in Ovarian Cancer: Can We Bridge the Gap Between IMagynation and Reality?
J Clin Oncol
.
2021 Jun 10;39(17):1833-1838.
doi: 10.1200/JCO.21.00571.
Epub 2021 Apr 23.
Authors
Panagiotis A Konstantinopoulos
1
,
Stephen A Cannistra
2
Affiliations
1
Dana-Farber Cancer Institute, Boston, MA.
2
Beth Israel Deaconess Medical Center, Boston, MA.
PMID:
33891471
DOI:
10.1200/JCO.21.00571
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Ovarian Epithelial
Female
Humans
Immune Checkpoint Inhibitors*
Ovarian Neoplasms* / drug therapy
Substances
Immune Checkpoint Inhibitors